Hong Kong stocks of innovative drugs strengthened in the afternoon, Rongchang Biopharma and China Biopharmaceutical rose by more than 15%

2025-06-12 13:16:10

Hong Kong stocks with innovative drug concepts strengthened in the afternoon, with Rongchang Biopharma and China Biologic Products rising by more than 15%, Junshi Biosciences, Zhaoyan Pharmaceutical, BeiGene, and CStone Pharmaceuticals rising by more than 5%.

BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Southbound funds made a large net purchase of 5.743 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), China Construction Bank and Meituan-W received net purchases of HK$1.108 billion and HK$493 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$1.489 billion; in terms of Hong Kong Stock Connect (Shenzhen), Meituan-W and Kangfang Biopharma received net purchases of HK$622 million and HK$206 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$391 million.
                            2025-06-16

                                    Arm (ARM.O): We are better than Nvidia on a wider range of platforms.
                            2025-06-12

                                    Lei Jun: Xiaomi Yu7 will be released at the end of June
                            2025-06-16

                                    Putin: Russia will create unmanned system forces as a separate branch of the military
                            2025-06-13

                                    Barclays: Raised Oracle (ORCL.N) price target from $202 to $221.
                            2025-06-13